Press Releases

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jul. 10, 2019-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the sale of certain AutoLap ® image-based

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jun. 6, 2019-- TransEnterix, Inc. (NYSE American:TRXC) announced today that Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the Raymond James Life Sciences and Medtech Conference at The Lotte New York Palace

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--May 28, 2019-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that it has received Japanese regulatory approval

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--May 9, 2019-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--May 7, 2019-- TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery , Executive Vice President and Chief Financial Officer, will present at the 2019 RBC Capital Markets

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Apr. 24, 2019-- TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release first quarter financial and operating results after the market closes on Thursday, May 9, 2019 . Todd M. Pope , President and Chief Executive Officer,

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Mar. 28, 2019-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery (MIS), today announced it will host several events highlighting

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Feb. 26, 2019-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Feb. 12, 2019-- TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release fourth quarter and fiscal year 2018 financial and operating results before the market opens on Tuesday, February 26, 2019 . Todd M.

Senhance Ultrasonic advanced energy capability broadens potential applicability of Senhance surgery in the United States RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jan. 15, 2019-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between